TY - JOUR
T1 - Diagnostic Validation of the Updated Pediatric Sepsis Biomarker Risk II for Acute Kidney Injury Prediction Model in Pediatric Septic Shock
AU - Stanski, Natalja L.
AU - Zhang, Bin
AU - Cvijanovich, Natalie Z.
AU - Fitzgerald, Julie C.
AU - Bigham, Michael T.
AU - Jain, Parag N.
AU - Schwarz, Adam J.
AU - Lutfi, Riad
AU - Allen, Geoffrey L.
AU - Thomas, Neal J.
AU - Baines, Torrey
AU - Haileselassie, Bereketeab
AU - Weiss, Scott L.
AU - Atreya, Mihir R.
AU - Lautz, Andrew J.
AU - Zingarelli, Basilia
AU - Standage, Stephen W.
AU - Kaplan, Jennifer
AU - Goldstein, Stuart L.
N1 - Publisher Copyright:
Copyright © 2024 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
PY - 2024/11/1
Y1 - 2024/11/1
N2 - OBJECTIVES: We previously derived the updated Pediatric Sepsis Biomarker Risk for Acute Kidney Injury (PERSEVERE-II AKI) prediction model, which had robust diagnostic test characteristics for severe AKI on day 3 (D3 severe AKI) of septic shock. We now sought to validate this model in an independent cohort of children to the one in which the model was developed. DESIGN: A secondary analysis of a multicenter, prospective, observational study carried out from January 2019 to December 2022. SETTING: Ten PICUs in the United States. PATIENTS: Children with septic shock 1 week to 18 years old admitted to the PICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Seventy-nine of 363 patients (22%) had D3 severe AKI, defined as Kidney Disease Improving Global Outcomes stage 2 or higher. Patients were assigned a probability of D3 severe AKI using the PERSEVERE-II AKI model. The model predicted D3 severe AKI with an area under the receiver operating characteristic curve of 0.89 (95% CI, 0.85–0.93), sensitivity of 77% (95% CI, 66–86%), specificity of 88% (95% CI, 84–92%), positive predictive value of 65% (95% CI, 54–74%), and negative predictive value of 93% (95% CI, 89–96%). These data represent an increase in post-test probability of D3 severe AKI with a positive test from 22% to 65%, and a prevalence threshold of 28%. On multivariable regression, the PERSEVERE-II AKI prediction model demonstrated greater adjusted odds ratio (aOR) for D3 severe AKI (aOR, 11.2; 95% CI, 4.9–25.3) and lesser aOR for failure of D3 renal recovery from early AKI (aOR, 0.31; 95% CI, 0.13–0.69). CONCLUSIONS: The PERSEVERE-II AKI model demonstrates consistently robust performance for prediction of new or persistent D3 severe AKI in children with septic shock. A major limitation is that actual D3 severe AKI prevalence is below the prevalence threshold for the test, and thus future work should focus on evaluating use in enriched populations.
AB - OBJECTIVES: We previously derived the updated Pediatric Sepsis Biomarker Risk for Acute Kidney Injury (PERSEVERE-II AKI) prediction model, which had robust diagnostic test characteristics for severe AKI on day 3 (D3 severe AKI) of septic shock. We now sought to validate this model in an independent cohort of children to the one in which the model was developed. DESIGN: A secondary analysis of a multicenter, prospective, observational study carried out from January 2019 to December 2022. SETTING: Ten PICUs in the United States. PATIENTS: Children with septic shock 1 week to 18 years old admitted to the PICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Seventy-nine of 363 patients (22%) had D3 severe AKI, defined as Kidney Disease Improving Global Outcomes stage 2 or higher. Patients were assigned a probability of D3 severe AKI using the PERSEVERE-II AKI model. The model predicted D3 severe AKI with an area under the receiver operating characteristic curve of 0.89 (95% CI, 0.85–0.93), sensitivity of 77% (95% CI, 66–86%), specificity of 88% (95% CI, 84–92%), positive predictive value of 65% (95% CI, 54–74%), and negative predictive value of 93% (95% CI, 89–96%). These data represent an increase in post-test probability of D3 severe AKI with a positive test from 22% to 65%, and a prevalence threshold of 28%. On multivariable regression, the PERSEVERE-II AKI prediction model demonstrated greater adjusted odds ratio (aOR) for D3 severe AKI (aOR, 11.2; 95% CI, 4.9–25.3) and lesser aOR for failure of D3 renal recovery from early AKI (aOR, 0.31; 95% CI, 0.13–0.69). CONCLUSIONS: The PERSEVERE-II AKI model demonstrates consistently robust performance for prediction of new or persistent D3 severe AKI in children with septic shock. A major limitation is that actual D3 severe AKI prevalence is below the prevalence threshold for the test, and thus future work should focus on evaluating use in enriched populations.
UR - http://www.scopus.com/inward/record.url?scp=85201088980&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85201088980&partnerID=8YFLogxK
U2 - 10.1097/PCC.0000000000003589
DO - 10.1097/PCC.0000000000003589
M3 - Article
C2 - 39115853
AN - SCOPUS:85201088980
SN - 1529-7535
VL - 25
SP - 1005
EP - 1016
JO - Pediatric Critical Care Medicine
JF - Pediatric Critical Care Medicine
IS - 11
ER -